Ioana Preston, MD, highlights treatment considerations for managing PAH in specific patient populations and discusses the ...

Posters presented at ASCO 2024 found positive responses in the prediction of tumor types and prognostic outcomes in patients ...

This investigation sprung from a lack of current knowledge on the impact of nonmalignant results following thoracic surgery ...

FDA advisers have voted against the use of MDMA as a post-traumatic stress disorder (PTSD) treatment; House members have ...

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, discusses promising pharmacological ...

Experts on Alzheimer disease discuss how the introduction of disease-modifying therapies has impacted the treatment landscape ...

The panel provides insights on the economic impact of advanced approaches for diagnosing Alzheimer disease, highlighting how ...

Ravin Ratan, MD, MEd, MD Anderson, delves into how treatment paradigms and considerations differ between adult patients and ...

Use of sodium oxybate and low-sodium oxybate led to meaningful improvements in patients with hypersomnia and narcolepsy ...

Panelists highlight the need for education and support to help clinicians appropriately prescribe prescription digital ...

In the final overall survival analysis of the phase 3 CARES-310 trial, frontline camrelizumab plus rivoceranib continued to ...

Chief Health Equity Officer and Senior Vice President Aletha Maybank, MD, MPH, of the American Medical Association (AMA), ...